Monaldi Archives for Chest Disease (Dec 2021)

E-cigarette, or vaping, product use Associated Lung Injury (EVALI): new scenarios for physicians and radiologists

  • Carmine Guarino,
  • Ilaria Pedicelli,
  • Francesco Perna,
  • Valentina Di Spirito,
  • Giuseppe Fiorentino,
  • Fabio Procaccini,
  • Gaetano Rea

DOI
https://doi.org/10.4081/monaldi.2021.1962

Abstract

Read online

A 59-year-old female ex-smoker with 40 pack year smoking history and a 5-year current e-cigarette (EC) use history, presented with progressive dyspnea on exertion and daily cough for 2 months. A CT scan showed a consolidation area with air bronchogram in the middle lobe and non-calcific bilateral nodules, which could be attributed to community-acquired pneumonia. The patient was treated with empiric antibiotics and systemic steroids for 10 days. Infectious, neoplastic and autoimmune pathologies were excluded, whereas a broncho-alveolar lavage revealed an accumulation of lipids in the cytoplasm of the alveolar macrophages. Despite the recommendation of vaping cessation, the patient continued to use EC. A new CT exam, carried out after 18 months, showed reversed halo sign (RHS), patchy ground-glass opacity (GGO), pleuro-parenchymal bands, and indeed perilobular pattern, suggestive of organizing pneumonia (OP). The final diagnosis was E-cigarette, or vaping, product use Associated Lung Injury (EVALI)- related OP.

Keywords